Uncategorized

Trade, budget reconciliation, and nominations are likely to dominate Washington this week. Meanwhile, current government funding expires on March 14 and Republicans and Democrats are still reportedly very far apart on top-line spending numbers for…

As we await the House’s budget reconciliation strategy this week, the Senate FY25 budget resolution proposal released late Friday bolsters our expectations for Medicaid work requirements, which we see as one the most likely Medicaid-related…

NIH’s surprise announcement Friday of a 15% cap on indirect costs for both new and existing grants will likely trigger fresh uncertainty for life science tools (LST) manufacturers. While indirect costs are technically distinct from…

Bicameral reintroduction this week of legislation to allow – not require – Medicare coverage of multi-cancer early detection (MCED) tests starting in 2028 bolsters our view of its likely inclusion in a mid-March spending bill…

News that the Senate is looking to mark up a budget resolution as early as next week reinforces our view that the Congress is going to pass two reconciliation bills as opposed to one.  We…

With the briefing in a federal lawsuit having concluded and Congress on the hunt for legislative savings, the question is when, not if, CMS’s minimum nurse staffing rule is killed, eliminating the overhang and potential…

At this early stage, we give tossup odds to Governor Mike DeWine’s (R-OH) budget proposal released yesterday, raising the state’s tax rate on sports betting from 20% to 40%, becoming law.  The budget now goes…

Both chambers of Congress are in session this week, but tariffs are likely to dominate the news flow. Meanwhile: Congressional leaders are trying to reach an agreement on FY25 spending levels. The House Budget Committees…

We continue to believe that President Trump will likely stick by his February 1 deadline for announcing 25% tariffs on Mexico and Canada for problems he sees at the border and fentanyl coming into the…

The four hours RFK spent with the Senate Finance Committee today bolsters our view that he is likely to be confirmed as HHS Secretary. Despite investor concerns with his antipathy for corporate medicine, we think…